Revealing of H. pylori markers at patients with acute viral hepatitises
https://doi.org/10.22625/2072-6732-2011-3-1-32-38
Abstract
O-antigenes of H. рylori have been revealed аt patients with acute viral hepatitis (AVH) (57,7%), more often at patients with a cholestasis, than without cholestasis (in feces – 48,6% and 35,4%, in CIC – 14,8% and 4,5%, accord., and VacA (43,5%) and a high-molecular fibers complex (70,6%). In aggregate with high indicators of LII and smaller linkage of toxins in the CIC in cholestasis, this data testifies to important pathogenetic role of H. рylori in development of cholestasis, induced by an inflammation.
About the Authors
S. N. Zuevskaja
The first Moscow medical university by I.M. Setchenov, Moscow
Russian Federation
Russian Federation
O. F. Belaja
The first Moscow medical university by I.M. Setchenov, Moscow
Russian Federation
Russian Federation
O. A. Paevskaja
The first Moscow medical university by I.M. Setchenov, Moscow
Russian Federation
Russian Federation
Ju. A. Belaja
Research Institute of epidemiology and microbiology by N.F. Gamaleja, Moscow
Russian Federation
Russian Federation
S. G. Pak
The first Moscow medical university by I.M. Setchenov, Moscow
Russian Federation
Russian Federation
References
1. Reichen, J. Cholestasis / J. Reichen [et al.] // Biology and Pathobiology. – New York: Raven Press Ltd, 1994. – P. 1291– 1325.
2. Crawford, J.M. Clinicopathology Conferences: Inflammation–Induced Colestasis / J.M. Crawford, J.L. Boyer // Hepatology. – 1998. – V. 28, № 1. – P. 253– 259.
3. Trauner, M. Inflammation-induced cholestasis /M. Trauner, P. Fickert, R.E. Stauber // J. astroenterol. Hepatol. – 1999. – V. 14, № 10. – P. 946–959.
4. Шерлок, Ш. Холестаз / Ш. Шерлок, Дж. Дули // Заболевание печени и жёлчных путей. – М., 1999. – С. 254–255.
5. Людеритц, О., Бактериальные антигены / О. Людеритц, Б.А. Дмитриев // Проблемы инфектологии ; под ред. С.В. Прозоровского. – М., 1991.
6. Яковлев, М.Ю. Роль кишечной микрофлоры и недостаточности барьерной функции печени в развитии эндотоксинемии и воспаления / М.Ю. Яковлев // Казанский мед. журнал. – 1988. – №5. – С. 353–358.
7. Пак, С.Г. Опыт и перспективы изучения синдрома интоксикации в инфекционной патологии / С.Г. Пак [и др.] //Журнал инфектологии. – 2009. – № 1. – С. 9–17.
8. Boutin, S.R. Different Helicobacter hepaticus strains with variable genomic content induce various degress of hepatitis /S.R. Boutin [et al.] // Infect. Immun. -2005. – V.73, № 12. – P. 8449–8452.
9. Fox, J.G. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens /J.G. Fox [et al.] // Gut. – 2010. – V. 59, № 1. – P. 88–97.
10. Stalke, P. Detection of Helicobacter species in liver and stomach tissues of patients with chronic liver diseases using polymerase chain reaction-denaturing gradient gel electrophoresis and immunohistochemistry / P. Stalke [et al.] //Scand. J. Gastroenterol. – 2005. – V. 40, № 9. – P. 1032–1041.
11. Casswall, T.H. Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease / T.H. Casswall [et al.] // Scand. J. Gastroenterol. – 2010. – V. 45, № 2. – P. 160–167.
12. Tian, X.F. Experimental study on the pathological effect of Helicobacter pylori on liver tissues / X.F. Tian [et al.] //Zhonghua Gan Zang Bing ZA Zhi. – 2005. –V. 13, № 10. – P. 780–783.
13. Huahg, Y. The pathological effect of Helicobacter pylori infection on liver tissues in mice / Y. Huahg [et al.] // Clin. Microbiol. Infect. – 2009. – V. 15, № 9. – P. 843–849.
14. Mamum-Al-Mahtab. State of the Globe: Helicobacter pylori and Hepatitis C Together Hamper Health / Mamum-Al-Mahtab // J. Glob. Infect. Dis. – 2010. – V. 2, № 1. – P. 1–3.
15. Chen, R. Status of H. pylori infection in the hepatic tissue of patients with hepatocarcinoma / R. Chen [et al.] //Nan Fang Yi Ke Da Xue Xue Bao. – 2010. – V. 30, № 5. –P. 1028–1030.
16. Rasmussen, M.E. Role of Helicobacter spacies in hepatobiliary diseases / M.E. Rasmussen, L.E. Lauritsen,L.P. Andersen // Ugeskr Laeger. – 2008. – V. 170, № 23. –P. 2010–2015.
17. Oldani, A. Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells / A. Oldani [et al.] // PLoS Pathog. –2009. – V. 5, № 10. – P. e1000603.
18. Белая, О.Ф. Реакция коагглютинации при кишечных инфекционных заболеваниях : метод. рекоменд. МЗ СССР /О.Ф. Белая [и др.]. – М., 1990. – 12 с.
19. Патент 2232989. Способ получения тест-системы для определения антигенов цитотоксинассоциированных белков Helicobacter pylori в биологическом материале инфицированных лиц реакцией коагглютинации / Белая, Ю.А. [и др.] ; зарег. в Госреестре изобретений 20 июля 2004 г.
Review
For citations:
Zuevskaja S.N., Belaja O.F., Paevskaja O.A., Belaja J.A., Pak S.G. Revealing of H. pylori markers at patients with acute viral hepatitises. Journal Infectology. 2011;3(1):32-38. (In Russ.) https://doi.org/10.22625/2072-6732-2011-3-1-32-38
Views:
489
.png)
.png)
Email this article 